Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus

被引:49
作者
Mojiminiyi, OA
Abdella, N
机构
[1] Kuwait Univ, Dept Pathol, Fac Med, Safat 13110, Kuwait
[2] Kuwait Univ, Dept Med, Fac Med, Safat 13110, Kuwait
关键词
beta-2; microglobulin; cystatin C; glomerular filtration rate; type 2 diabetes mellitus; diabetic nephropathy;
D O I
10.1016/S1056-8727(02)00177-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite recent studies showing that serum cystatin C (CC) is a better marker for GFR than the ubiquitously used serum creatinine, its clinical utility remains under evaluation. Methods: To evaluate their usefulness in patients with type 2 diabetes mellitus (DM) serum concentrations of CC, beta-2 microglobulin (B2M) and creatinine were measured in 105 (38 males, 67 females) Kuwaiti patients with type 2 DM. The results were compared with creatinine clearance (Ccr), which was measured (mCcr) and estimated (eCcr) with the Cockroft-Gault formula, and correlated with 24-h urine protein and early morning urine albumin/creatinine excretion ratio. Results: In patients with eCcr and mCcr results (n = 51), eCcr and mCcr showed significant correlation with each other (r's = .86, P < .0001) with no significant difference between the two. In all patients (n = 105), CC and B2M showed significant correlation with each other (r's = .82, P < .0001) and with serum creatinine concentration (r's = .77 and .84, respectively, P < .0001). Serum CC, B2M and creatinine showed significant (P < .001) inverse correlation with eCcr (r's = -.63, -61 and -.76, respectively). Partial correlations after correcting for age and sex improved the correlation of serum creatinine with eCcr (r = -.81, P < .0001), but there was no significant change in the correlations of CC and B2M with eCcr (r = -.65, P < .0001 and r = -.62, P < .0001, respectively). Receiver operating characteristic (ROC) plots for serum CC, B2M and creatinine for detection of changes in the eCcr showed that the area under the ROC curve ±S.E. is 0.897 ± 0.119 for CC, 0.871 ± 0.091 for B2M and 0.785 ± 0.087 for serum creatinine. There was no statistically significant difference between the areas under the curve (AUC) for serum creatinine and CC (P = .07) and B2M (P = .12). CC had the highest sensitivity for detection of eCcr (< 60 mt/min/1.73 m(2)) at routinely used cutoff values. CC was also the best discriminator when patients with normoalbuminuria were compared with patients with microalbuminuria. Conclusion: Although there is no significant difference in the overall diagnostic accuracies of CC, B2M and creatinine for the detection of changes in the GFR, CC is the most sensitive marker at routinely used cutoff values and would be more clinically useful than B2M or serum creatinine in diabetic patients. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:160 / 168
页数:9
相关论文
共 41 条
[1]  
American Diabetes Association, 1998, DIABETES CARE, pS23
[2]   MEASUREMENT OF GLOMERULAR-FILTRATION RATE IN HOMOZYGOUS SICKLE-CELL DISEASE - A COMPARISON OF CR-51 EDTA CLEARANCE, CREATININE CLEARANCE, SERUM CREATININE AND BETA-2 MICROGLOBULIN [J].
APARICIO, SAJ ;
MOJIMINIYI, S ;
KAY, JDS ;
SHEPSTONE, BJ ;
DECEULAER, K ;
SERJEANT, GR .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (05) :370-372
[3]   RELATIVE SENSITIVITY OF SERUM AND URINARY RETINOL BINDING-PROTEIN AND ALPHA-1 MICROGLOBULIN IN THE ASSESSMENT OF RENAL-FUNCTION [J].
AYATSE, JOI ;
KWAN, JTC .
ANNALS OF CLINICAL BIOCHEMISTRY, 1991, 28 :514-516
[4]   EFFECT OF GLYCEMIC CONTROL ON EARLY DIABETIC RENAL LESIONS - A 5-YEAR RANDOMIZED CONTROLLED CLINICAL-TRIAL OF INSULIN-DEPENDENT DIABETIC KIDNEY-TRANSPLANT RECIPIENTS [J].
BARBOSA, J ;
STEFFES, MW ;
SUTHERLAND, DER ;
CONNETT, JE ;
RAO, KV ;
MAUER, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (08) :600-606
[5]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]   The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].
Caramori, ML ;
Fioretto, P ;
Mauer, M .
DIABETES, 2000, 49 (09) :1399-1408
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]   Creatinine clearance as a measure of GFR in screenees for the African-American study of kidney disease and hypertension pilot study [J].
Coresh, J ;
Toto, RD ;
Kirk, KA ;
Whelton, PK ;
Massry, S ;
Jones, C ;
Agodoa, L ;
Van Lente, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) :32-42
[9]  
De Fronzo RA, 1995, DIABETES REV, V3, P510
[10]  
FELDTRASMUSSEN B, 1986, LANCET, V2, P1300